bluebird bio, Inc.: cash_and_equivalents
| Value | {"amount": 260629000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2020-12-31) |
| Status | current |
| Entity | bluebird bio, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T12:19:00.273213+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/e2e1eba6-a956-406e-8738-300b0f8f73b7
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001293971-22-000016 · Open the official SEC filing →Retrieved: 2026-08-19T12:19:00.273213+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001293971/cash-and-equivalents/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/e2e1eba6-a956-406e-8738-300b0f8f73b7
History
- supersedes {"amount": 317705000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} (evidence 0001293971-21-000013)